"Major Funding Injected into Chronic Lyme Disease Research"
The National Institutes of Health has awarded federal grants to two Massachusetts teams to study chronic Lyme disease, a condition that affects 10-20% of people with Lyme disease and shares similarities with long COVID. The research aims to develop a better understanding of the causes of chronic Lyme and potentially develop effective therapies. One study led by Michal Caspi Tal at MIT is analyzing the "antibody signature" in Lyme patients to develop a diagnostic test. Another study led by Dr. Linden Hu at Tufts Medical School is investigating the theory that an autoimmune response to phospholipids may be responsible for chronic Lyme symptoms. The studies offer hope for better diagnosis and treatment options for chronic Lyme patients.